Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $217K | +2.32K | +17.06% | $93.53 | 15.9K | Mar 6, 2024 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$124K | -678 | -4.25% | $182.88 | 15.3K | Mar 6, 2024 | Direct | F1 |
transaction | RGA | Common Stock | Sale | -$347K | -1.91K | -12.49% | $181.84 | 13.4K | Mar 6, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2016 | Options Exercise | $0 | -4.76K | -100% | $0.00* | 0 | Mar 6, 2024 | Common Stock | 4.76K | $93.53 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents (i) 2,434 shares sold to pay the exercise price the purchase of common stock, and (ii) 678 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 1,646 shares. |
F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |